Involvement of Ferroptosis Induction and Oxidative Phosphorylation Inhibition in the Anticancer-Drug-Induced Myocardial Injury: Ameliorative Role of Pterostilbene
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25053015 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kiyomu Fujii und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan. Hauptthemen laut MEDLINE: Ferroptosis, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, MEXT KAKENHI.
Abstract (Originalsprache)
Patients with cancer die from cardiac dysfunction second only to the disease itself. Cardiotoxicity caused by anticancer drugs has been emphasized as a possible cause; however, the details remain unclear. To investigate this mechanism, we treated rat cardiomyoblast H9c2 cells with sunitinib, lapatinib, 5-fluorouracil, and cisplatin to examine their effects. All anticancer drugs increased ROS, lipid peroxide, and iron (II) levels in the mitochondria and decreased glutathione peroxidase-4 levels and the GSH/GSSG ratio. Against this background, mitochondrial iron (II) accumulates through the unregulated expression of haem oxygenase-1 and ferrochelatase. Anticancer-drug-induced cell death was suppressed by N-acetylcysteine, deferoxamine, and ferrostatin, indicating ferroptosis. Anticancer drug treatment impairs mitochondrial DNA and inhibits oxidative phosphorylation in H9c2 cells. Similar results were observed in the hearts of cancer-free rats treated with anticancer drugs in vitro. In contrast, treatment with pterostilbene inhibited the induction of ferroptosis and rescued the energy restriction induced by anticancer drugs both in vitro and in vivo. These findings suggest that induction of ferroptosis and inhibition of oxidative phosphorylation are mechanisms by which anticancer drugs cause myocardial damage. As pterostilbene ameliorates these mechanisms, it is expected to have significant clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, Japan.
ORCID-Profile: Hiroki Kuniyasu
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- MEXT KAKENHI
Zitieren
APA
Fujii, K., Fujiwara-Tani, R., Nukaga, S., Ohmori, H., Luo, Y., Nishida, R., Sasaki, T., Miyagawa, Y., Nakashima, C., Kawahara, I., Ogata, R., Ikemoto, A., Sasaki, R., & Kuniyasu, H. (2024). Involvement of Ferroptosis Induction and Oxidative Phosphorylation Inhibition in the Anticancer-Drug-Induced Myocardial Injury: Ameliorative Role of Pterostilbene. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25053015
Vancouver
Fujii K, Fujiwara-Tani R, Nukaga S, Ohmori H, Luo Y, Nishida R, et al. Involvement of Ferroptosis Induction and Oxidative Phosphorylation Inhibition in the Anticancer-Drug-Induced Myocardial Injury: Ameliorative Role of Pterostilbene. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25053015
BibTeX
@article{Fujii2024,
author = {Fujii, Kiyomu and Fujiwara-Tani, Rina and Nukaga, Shota and Ohmori, Hitoshi and Luo, Yi and Nishida, Ryoichi and Sasaki, Takamitsu and Miyagawa, Yoshihiro and Nakashima, Chie and Kawahara, Isao and Ogata, Ruiko and Ikemoto, Ayaka and Sasaki, Rika and Kuniyasu, Hiroki},
title = {Involvement of Ferroptosis Induction and Oxidative Phosphorylation Inhibition in the Anticancer-Drug-Induced Myocardial Injury: Ameliorative Role of Pterostilbene},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25053015}
}
EUVIMED